Vancouver, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has engaged FN Media Group, LLC (“FN Media”) to commence news/media marketing campaigns for a three (3) day term commencing the week of October 20, 2025, in consideration of USD$14,085. FN Media shall utilize its proprietary traffic generation application and Google/Yahoo Digital media ads platforms. FN Media does not currently ...

Core Insights - Rocket Doctor AI Inc.'s subsidiary, Treatment.com Inc., has been awarded a $2 million NIH SBIR Phase II grant to develop an AI-powered, culturally sensitive family medical history tool aimed at improving early diagnosis and preventive care for diverse populations [1][7]. Funding and Project Details - The two-year grant will provide over $500,000 to Treatment for enhancing its capabilities in handling medical history data across various commercial platforms [2][7]. - The project builds on research advances from Phase 1 and aims to leverage AI to collect and apply family health history, particularly focusing on African American communities that experience higher mortality rates from certain diseases [3][4]. Collaboration and Expertise - Treatment is collaborating with Rush River Research, which brings expertise in engineering, design, and NIH grant management to the project [4][8]. - The partnership aims to create AI systems that are more accurate and human-centered by addressing historical, genetic, and cultural differences in health [5]. Goals and Impact - The initiative seeks to facilitate informed conversations about family health history, thereby enhancing preventive care, early diagnosis, and targeted screening [3][4]. - Insights gained from this project will not only benefit African American communities but will also be applicable to improve family health history for all populations [3][7]. Company Background - Rocket Doctor AI Inc. focuses on delivering AI-powered healthcare solutions designed to enhance access to quality healthcare throughout the patient journey [9][10]. - The company's Global Library of Medicine (GLM) serves as a clinically validated decision support system, supporting healthcare providers in delivering effective care [9][11].

Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop secure communications functionality, and funding of up to $25,000 from the CanExport SMEs program to accelerate produ ...

Vancouver, BC, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, due to the Canada Postal Strike, there is a delay in the mailing of the Company’s proxy circular and related documents pertaining to the Company’s Annual General Meeting (the “Meeting”) of the shareholders to be held on Wednesday, October 22, 2025 at the hour of 10:00 a.m. (Pacific Time) at the offices of McMillan LLP, Suite 1500 – 1055 West Georgia Street, Vanc ...

Core Insights - Rocket Doctor AI Inc. is a healthcare technology company focused on AI-powered solutions to enhance healthcare accessibility throughout the patient journey [1][3] - The company will present at the CANTech Letter Investment Conference on October 9, 2025, highlighting its platform, recent milestones, and growth strategy [1][2][6] Company Overview - Rocket Doctor AI delivers physician-built, AI-powered solutions aimed at making high-quality healthcare accessible [3] - The company's technology includes the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from numerous physicians globally [3] Technology and Impact - The company has empowered over 300 MDs to provide care for more than 700,000 patient visits, enabling doctors to manage their own virtual or hybrid practices [4] - By reducing administrative burdens, the technology allows for more meaningful physician-patient interactions and aims to improve access to care for underserved communities in Canada and patients on Medicaid and Medicare in the U.S. [5] Conference Participation - Dr. Essam Hamza and Dr. William Cherniak will present at the conference, discussing how Rocket Doctor AI's solutions streamline workflows and improve patient outcomes [2][6]

Core Viewpoint - Rocket Doctor AI Inc. has filed a prospectus supplement to qualify the distribution of securities related to 3,677,400 special warrants issued on August 21, 2025, which will convert into common shares and warrants on October 2, 2025 [1][3]. Group 1: Offering Details - The prospectus supplement qualifies the distribution of 3,677,400 common shares and 3,677,400 common share purchase warrants, with each warrant allowing the holder to acquire one common share at an exercise price of $0.75 for 12 months from issuance [2]. - The special warrants will automatically convert into common shares and warrants without any action required from the holders [3]. Group 2: Accessibility of Documents - The shelf prospectus and the prospectus supplement are accessible on SEDAR+ and can be obtained from the company without charge [4]. Group 3: Company Overview - Rocket Doctor AI Inc. provides AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, featuring a Global Library of Medicine (GLM) developed with input from numerous physicians [6][8]. - The company has empowered over 300 MDs to manage more than 700,000 patient visits, improving efficiency and expanding patient access to care [7].

Core Insights - Rocket Doctor AI Inc. has achieved in-network status with Maryland Medicaid and Medicare, allowing it to serve a significant portion of Maryland's population [1][2][5] - This development enhances access to healthcare services for over 2.6 million Maryland residents, including urgent care, chronic disease management, preventive health, and mental health care [2][3][8] - The initiative aligns with Maryland's healthcare policies aimed at improving population health, equity, and reducing costs [5][8] Company Overview - Rocket Doctor AI Inc. offers AI-powered healthcare solutions designed to enhance accessibility throughout the patient journey, utilizing a clinically validated decision support system [6][7] - The company has facilitated over 700,000 patient visits through its digital health platform, empowering physicians to manage virtual or hybrid practices [7][8] - The technology aims to reduce administrative burdens, allowing for more meaningful interactions between physicians and patients, particularly in underserved communities [8] Market Impact - The in-network arrangement is expected to bridge care gaps for Medicaid and Medicare beneficiaries, particularly in rural and underserved areas where access to healthcare is challenging [4][8] - The move supports the company's mission to promote health equity and complements existing pharmacy-based programs and partnerships [4][5] - By aligning with state priorities, Rocket Doctor AI is positioned to effectively serve vulnerable populations in Maryland [5][8]

Core Insights - Rocket Doctor AI Inc. has formed a partnership with the Town of Bruderheim, Alberta, to provide virtual healthcare services fully covered by Alberta Health, marking its first collaboration with a Canadian municipality [1][4] - The partnership aims to enhance access to essential healthcare services for Bruderheim residents, addressing challenges faced by rural communities such as staffing shortages and geographic isolation [2][3] Group 1: Partnership Details - The partnership officially launches on September 15, 2025, and will automatically renew on July 10, 2026, for subsequent one-year periods under identical terms [1][7] - Bruderheim residents will have access to a physician-led platform for video and audio appointments with licensed Alberta medical professionals, covering services like urgent care, chronic disease management, preventive health, and comprehensive primary care [2][7] Group 2: Healthcare Challenges - Rural communities in Canada, including Bruderheim, face significant healthcare challenges, including limited access due to staffing shortages, long travel times, and higher health risks [3][4] - The Government of Alberta has recognized these disparities and introduced initiatives like the Rural Health Action Plan (2024–2027) to improve healthcare access in rural areas [4] Group 3: Company Growth and Mission - Rocket Doctor AI has reported strong growth in Alberta, serving over 71,000 Albertans, with 35% from communities with populations under 25,000 [5] - The company aims to bridge gaps in rural healthcare delivery through innovative technology, emphasizing its commitment to partnering with public healthcare systems [5][11]

Core Viewpoint - Rocket Doctor AI Inc. has achieved in-network status with Aetna in New York, enhancing access to its digital health services for Aetna members, particularly those on Medicare and Medicaid [1][8]. Group 1: Company Developments - Rocket Doctor's digital health platform now provides in-network care to Aetna members in New York, combining urgent care, primary care, and mental health services [2][8]. - The company has been fully credentialed for Medicare and commercial plans, allowing Aetna members to access services with lower out-of-pocket costs [3][8]. - Rocket Doctor is actively involved in New York through partnerships, including the Healthy Aging Program with CVS Health Foundation, which offers free virtual health screenings for adults over 60 [4][8]. Group 2: Technology and Services - The company utilizes AI-powered solutions and a proprietary technology platform to improve healthcare delivery, enabling over 300 MDs to manage more than 700,000 patient visits [9][10]. - Rocket Doctor's technology aims to reduce administrative burdens, allowing for more meaningful interactions between physicians and patients [10]. Group 3: Market Position and Growth - The credentialing with Aetna strengthens Rocket Doctor AI's presence in the U.S. market and aligns with its mission to enhance healthcare access and equity [8]. - The company continues to expand its partnerships across North America, indicating a growth trajectory in the digital health sector [5].

Core Insights - Rocket Doctor AI Inc. reported its first significant revenue quarter in Q2 2025, generating $0.5 million, primarily due to the acquisition of Rocket Doctor Inc. [5][6] - The company completed the acquisition of Rocket Doctor Inc. on April 10, 2025, enhancing its digital health platform and expanding its operational capabilities [4][12] - The company is focusing on U.S. expansion and has secured new contracts, including a virtual-care partnership with Central California Alliance for Health, serving approximately 450,000 members [5][23] Financial Highlights - Q2 2025 revenue was $0.5 million, compared to $0 in Q1 2025 and Q2 2024, marking a significant increase attributed to the Rocket Doctor acquisition [6] - Gross margin for Q2 2025 was 89%, a notable improvement from 0% in previous quarters, driven by revenue from the digital health platform [6][27] - The net comprehensive loss for Q2 2025 was $2.7 million, or $0.04 per share, consistent with the loss reported in Q1 2025 but an improvement from $2.7 million or $0.07 per share in Q2 2024 [6][27] Corporate Developments - The company has shifted its business model from B2C to B2B, aligning with the demand for AI-driven solutions in healthcare systems and academic institutions [8] - The Global Library of Medicine (GLM) is central to the company's strategy, providing clinical decision support and educational tools [7][21] - The company has made significant investments in enhancing its platform architecture and API capabilities, positioning itself for accelerated commercialization [24] Market Opportunity - The global AI healthcare market is projected to exceed USD $180 billion by 2030, driven by the demand for efficiency and accuracy in clinical workflows [9] - The conversational AI segment is expected to grow from approximately USD $13.5 billion in 2024 to between USD $49 billion and $123 billion by 2030, indicating a ~24% CAGR [9] Product Development - The Medical Education Suite (MES) was successfully deployed to 240 medical students at the University of Minnesota, showcasing the potential of AI-driven tools in medical education [15][24] - Rocket Doctor's technology solutions, including Starship EMR and RD Connect, are designed to streamline workflows and reduce care delivery costs [12][19] - The company is actively developing an AI Pharmacy Assistant, with integration plans involving over 20 pharmacies [18]